FGF19 and esophageal squamous cell carcinoma: Amplification of MCL1 (24/58, 41.4%), FGF19 (23/58, 39.7%), CCND1 (22/58, 37.9%), and MYC (20/58, 34.5%) was the four dominant types of CNV identified in this ESCC cohort.